Bonmax Pth 750Mcg Pre-Filled Pen 3ml Injection

Bonmax PTH 750 mcg (3 ml) is a teriparatide-based anabolic therapy indicated for severe osteoporosis in men and postmenopausal women at high fracture risk. As a recombinant parathyroid hormone analogue, bonmax pth injection stimulates new bone formation, improves bone mineral density, and reduces vertebral fracture risk. This bonmax injection is administered subcutaneously using a calibrated pen device under medical supervision, typically for up to 24 months as advised by the treating physician.

Key Benefits

• Stimulates osteoblastic activity to promote new bone formation
• Clinically proven to reduce vertebral and non-vertebral fracture risk
• Improves bone mineral density in high-risk osteoporosis patients
• Suitable for glucocorticoid-induced osteoporosis cases
• Convenient daily dosing via bonmax injection pen
• Designed for predictable dosing accuracy and caregiver ease.

Teriparatide (750mcg).

This is a subcutaneous injection (the site of administration for this drug is subcutaneous tissue; it is mostly administered at the abdomen 2 inches away from the belly button, upper arm, or upper thigh).

Step 1: Locate & clean a 2-inch area around the site with an alcohol swab or pad.

Step 2: Uncap the pen needle & replace the needle if needed.

Step 3: Insert the needle into the vein at a 45° angle from the skin.

Step 4: Withdraw the needle at the same angle & press a cotton ball over the site.

NOTE: Do not self-administer unless trained by healthcare professionals.

• Keep in cool, dry place, out of direct sunlight.
• Do not exceed a total of 24 months in your lifetime.
• Ensure appropriate stock refrigeration between 2° C to 8° C.
• Avoid use during pregnancy or if planning to conceive.
• Inform your doctor about all ongoing medications to avoid interactions.
• Not suitable for patients with Paget's disease
• Not suitable for patients with risk of bone cancer or under skeletal radiation therapy.